GGrantIndex
← Leaderboards

Anticancer, Inc.

San Diego, CA

Compare ↔
$6,830,793
Total funding
20
Grants

Funding over time

peak $1.3M · FY200517
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$6,830,793 · 20

By mechanism

R44$3,926,449 · 5
R43$2,904,344 · 15

Investigators at Anticancer, Inc.

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Largest grants

RHOMOCYSTEINASE FOR HOMOCYSTEINE ASSAY$463,300
R44 · FY2001 · HL
RHOMOCYCSTEINASE FOR HOMOCYSTEINE ASSAY$451,736
R44 · FY2002 · HL
Targeted tumoricidal bacteria$386,199
R44 · FY2011 · CA
Dual-color tumor-host imaging models$375,784
R44 · FY2006 · CA
Dual-color tumor-host imaging models$375,784
R44 · FY2007 · CA
Targeted tumoricidal bacteria$374,950
R44 · FY2010 · CA
Orthotopic models of tumor angiogenesis and blood flow$374,848
R44 · FY2007 · CA
Orthotopic models of tumor angiogenesis and blood flow$374,848
R44 · FY2006 · CA
Therapeutic hair follicle-derived neurospheres$374,500
R44 · FY2007 · AR
Therapeutic hair follicle-derived neurospheres$374,500
R44 · FY2006 · AR
GFP IMAGING FOR IN VIVO HIGH-THROUGHPUT DRUG SCREENING$250,000
R43 · FY2001 · CA
Hair follicle nestin-expressing stem cells on a scaffold for nerve repair$224,700
R43 · FY2014 · NS
Pancreatic-Cancer Imageable Patient-Derived Orthotopic Xenografts (iPDOX)$224,700
R43 · FY2014 · CA
Establishment of a patient-like mouse models of soft-tissue sarcoma sub-types$224,700
R43 · FY2017 · CA
NEW PEGYLATED MOLECULES OF RECOMBINANT METHIONINASE$219,420
R43 · FY2000 · CA
NEW PEGYLATED MOLECULES OF RECOMBINANT METHIONINASE$192,850
R43 · FY2001 · CA
Inhibitors of 5alpha-reductase for acne therapy$149,800
R43 · FY2002 · AR
Orthotopic models of tumor angiogenesis and blood flow$149,800
R43 · FY2003 · CA
Dual-color tumor-host imaging models$149,800
R43 · FY2003 · CA
Enzyme therapy for hyperhomocysteinemia$149,800
R43 · FY2005 · HL